Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 6Melanoma 5Clear-cell metastatic renal cell carcinoma 4Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Urachal adenocarcinoma 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sjogren's Syndrome 1Scleroderma, Systemic 1Psoriasis 1Prostatic Neoplasms 1Penile Neoplasms 1Nasopharyngeal Carcinoma 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Sclerosis 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell 1Lupus Erythematosus, Systemic 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Inflammatory Bowel Diseases 1Immunoblastic Lymphadenopathy 1Hematologic Neoplasms 1Endometrial Neoplasms 1

Interventions

Drug Therapy 2trastuzumab deruxtecan 1spartalizumab 1sacituzumab govitecan 1Radiotherapy 1Nivolumab 1Interleukin-2 1Fecal Microbiota Transplantation 1Docetaxel 1Cyclophosphamide 1Cisplatin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Drug-Related Side Effects and Adverse Reactions × CTLA-4 Antigen × Clear all
NCT04659343 2026-05-04

TDM for Optimized Outcome in Patients With mRCC.

University of Aarhus

Recruiting
200 enrolled
Genitourinary

Kidney Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡